Wuhan Uni-science Biotechnology Co., Ltd., located in Biolake (a national bio-industry base), is a high-tech enterprise specializing in the R & D, production, sales and technical services of in vitro diagnostic reagent products. It has been rated as "Optics Valley gazelle" enterprise.
The company has built three major technology platforms - colloidal gold immunochromatography platform, fluorescence immunochromatography platform and pathological diagnosis antibody platform, with independent R&D and production capacity of core raw materials. More than 80 POCT immunochromatographic qualitative and quantitative detection products (colloidal gold and fluorescent immunochromatography) have been successfully developed, which mainly cover cardiovascular diseases, kidney diseases, diabetes, infectious diseases, reproductive health, drug abuse, rheumatoid, gastrointestinal diseases, thyroid function, AIDS, Alzheimer's disease, bone metabolism and other diseases. In terms of pathological diagnosis antibodies, there are more than 200 kinds of marker antibodies. Each antibody has been identified by more than 1000 cancer and adjacent tissues, covering most tumor markers in the human body, and is applied to the pathological histochemical detection of multiple systems in the human body. Adhering to the values of “Open and enterprising, keep striving; Team-working, self-criticism; Everything with sincerity, everything for customer”, the company strives to expand the layout of the medical and health field with the mission of "Focusing on the Challenges and Pressures Concerned by Customers and Providing Competitive Products and Solutions in the Field of Life Science and Health". The company has passed the TÜV Rheinland ISO13485 quality management system certification. At present, it has obtained 41 class II medical device registration certificates and 294 class I medical device filing certificates. In addition, 112 products have obtained EU CE certification and MOH registration certification in dozens of countries. The company's products have been sold to more than 50 countries and regions around the world, contributing to the cause of human health.